Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Edison Investment Research
$10.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Trimel Pharmaceuticals Corp announces retirement of chair and appointment of new chair


Friday, 10 Jan 2014 05:05pm EST 

Trimel Pharmaceuticals Corp:Says the retirement of Bruce Brydon as Chair of the Board of Directors and as a Director.Says the Board has appointed Ian Ihnatowycz, currently a Director of Trimel, as Chair of the Board of Directors.Says both changes are effective Jan. 15, 2014. 

Company Quote

0.7
0.0 +0.00%
11 Jul 2014